CVSA Covista Inc. Common Shares

NYSE · Diversified Consumer Services · Auf SEC EDGAR ansehen ↗
$133,80
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026

Über Covista Inc. Common Shares Unternehmensübersicht von Wikipedia

Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.

Mehr lesen

Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.

Before June 2018, the corporation was known as DeVry Education Group Inc. Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017. Adtalem began the process to sell off DeVry University and Keller Graduate School of Management later that year to focus on healthcare professional education. Adtalem subsequently renamed itself Covista in 2026.

History

DeVry Inc. was created in 1987 with the merger of DeVry Institute of Technology (DIT) and the Keller Graduate School of Management. DIT was established in Chicago as the DeForest Training School in 1931 and was acquired by Bell & Howell in 1967. Keller was started by two DIT teachers in 1973; the company acquired DIT from Bell & Howell in 1987. DeVry Inc. went public in 1991, moved to the New York Stock Exchange in 1995, and became known as DeVry Education Group in 2013. The company was previously based in Downers Grove, Illinois.

In 2012, the company moved 150 jobs from its campus in Roscoe Village to a new office in Chicago's West Loop. The company had additional offices in Oak Brook, as of 2013. In 2015, the company opened another office in the West Loop, after the city approved a $1 million subsidy for the company in the form of tax increment financing in 2012.

In November 2013, DeVry Inc. was renamed DeVry Education Group.

Rebranding from DeVry Education Group to Adtalem Global Education

Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017 and began the process to sell off DeVry University and Keller Graduate School of Management later that year. The company stated that the new name signified a renewed focus on professional education in the health care and financial services sectors. Industry analysts characterized the move as an effort to move on from DeVry's legal, financial and reputational challenges.

Inside Higher Ed said, "Even before the new name change, the company has sought to differentiate itself publicly from the rest of the for-profit sector. It has responded to increased regulatory scrutiny -- and negative headlines -- for the sector by announcing self-imposed reforms such as voluntarily limiting the amount of revenue it takes in from federal aid."

The company's headquarters were later relocated from Downers Grove to 500 West Monroe Street in the West Loop Gate. In 2024, Crain's Chicago Business said Adtalem had become "the largest health care educator in the nation during a post-COVID period in which the health care sector has faced severe labor shortages". In November 2024, Adtalem announced plans to expand office capacity by moving to an 84,000-square-foot space in Willis Tower in early 2025. In late 2024, Adtalem partnered with Hippocratic AI to train health care professionals on using artificial intelligence.

Acquisitions and divestitures

Adtalem acquired Becker CPA Review (now known as Becker Professional Education), which prepared students for the Certified Public Accountant exam, in 1996. Adtalem acquired Ross University School of Veterinary Medicine in 2003, Chamberlain University (then Deaconess School of Nursing) in 2005, and American University of the Caribbean in 2011. Adtalem agreed to purchase Walden University for approximately $1.5 billion in September 2020. The agreement required approval by the U.S. Department of Education and the Higher Learning Commission. When the deal closed in August 2021, Adtalem became the largest provider of graduate and undergraduate degrees in nursing.

At the time of the re-branding, approximately half of Adtalem's 225,000 students were based in Brazil and approximately one fifth were studying healthcare. Adtalem went on to divest from the Brazil operations in May 2020.

Adtalem began selling business units unrelated to healthcare education in 2017 and consolidated focus on the industry during 2019–2020, when there was a shortage of health professionals. In 2018, the company sold Carrington College to San Joaquin Valley College, as well as DeVry University to Cogswell Education. In 2019, Kaplan, Inc. acquired Becker's healthcare test preparation assets. Kaplan also agreed to provide Adtalem with U.S. Medical Licensing Examination review programs to Ross University School of Medicine and American University of the Caribbean. In 2022, Colibri Group acquired Becker and OnCourse Learning from Adtalem. Adtalem also sold the Association of Certified Anti-Money Laundering Specialists to the French investment company Wendel. The specific purchase terms were not disclosed, but Adtalem confirmed that its financial services segment, which included ACAMLS, Becker, and OnCourse, sold for $1 billion. Since selling its financial services education business, Adtalem has focused primarily on healthcare education.

Operations

Campuses and enrollment

Adtalem's institutions operated approximately 130 campuses globally in 2018. Twelve of the 90 U.S. campuses were located in Illinois. In 2020, Adtalem's businesses operated 26 campuses in four countries and fifteen U.S. states. Approximately 90,000 students attended schools with a combined 6,100 faculty members. According to Adtalem, 34 percent of the students were Black. The company also claimed to be the largest provider of Master's, doctorate, and nursing degrees for African Americans. As of 2021, approximately 82 percent of the 140,000 students enrolled at Adtalem schools learned via distance education. In 2022, Adtalem operated 27 campuses and offered courses in 209 countries and territories.

Leadership

Stephen Beard, who was previously Adtalem's chief operating officer, became the chief executive officer (CEO) in 2021. He was appointed the chair of the board of directors in November 2024, succeeding Michael W. Malafronte. Beard was included in Time magazine's 2025 "Time100 Health" list of influential people in the healthcare industry.

Chris Begley was the board chair in 2016. Daniel Hamburger and Lisa Wardell have previously held the CEO role. Wardell was appointed in 2016. She was the only Black woman to lead a Fortune 1000 company in 2018, according to Crain's Chicago Business. Wardell was also the board chair in 2019. In 2021, an analysis by the University of Illinois Urbana-Champaign ranked Adtalem in the top five Illinois-based public firms for both gender and racial diversity on the board.

Finances

In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students. In 2017, Adtalem lost approximately $4.6 million from the impacts of Hurricane Irma and Hurricane Maria. The company made a profit of $95.6 million in 2019 and lost $85.8 million in 2020, suffering from enrollment declines during the COVID-19 pandemic. In early 2024, Adtalem was targeted by a short seller and the company announced a $300 million repurchase program. In late 2024, Investor's Business Daily said Adtalem saw an average sales growth of fourteen percent over the last three years. For the 2024 fiscal year, Adtalem repurchased 5.446 million shares for approximately $261 million. In May 2025, the repurchase was completed and a new stock buyback program of up to $150 million through May 2028 was launched.

Controversies

Covista, formerly known as DeVry Education Group, has been the subject of numerous investigations and lawsuits alleging that a variety of false or deceptive practices. While the group has generally denied the allegations, several cases led to multi-million dollar settlements.

In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students.

Months after the FTC settlement, DeVry Education Group rebranded as Adtalem Global Education in May 2018. Adtalem rebranded as Covista in 2026.

For-profit higher education in the United States has been the subject of hearings by the United States Senate Committee on Health, Education, Labor, and Pensions. Specifically regarding DeVry, the Committee found that over half of the students enrolled at DeVry in 2008-2009 withdrew by mid-2010. As of 2015, DeVry spent more on marketing than on student instruction.

As of 2013, DeVry Inc. was under investigation by the Attorneys General of the states of Illinois and Massachusetts.

In 2014, accumulated student loan debt from DeVry University and Keller, its graduate school, had reached approximately $12.1 billion.

A lawsuit filed against DeVry alleged deceptive recruiting practices in violation of federal law.

In January 2016, The Federal Trade Commission filed a lawsuit against DeVry Education Group alleging false or misleading advertising. A class action lawsuit was also filed against DeVry Group in US District Court, Northern District of California claiming breaches of contract, good faith and fair dealing, violations of the California Unfair Trade Practices Act, the California False Advertising Act and the California Consumer Legal Remedies Act, and negligent misrepresentations. A confidential settlement was reached.

In May 2016, a shareholder class action lawsuit was filed against DeVry Group, in the US District Court, Northern District of Illinois. The plaintiffs claimed that defendants made false or misleading statements regarding DeVry University's graduate employment rate and the earnings of DeVry University graduates relative to the graduates of other universities and colleges. The case was settled in 2019 for $27.5 million.

In December 2017, a former administrator filed a civil lawsuit number with the Los Angeles Superior Court, seeking relief for a number of causes of action including Retaliation and Wrongful Termination in Violation of Public Policy for complaining about an incentive-based compensation program that rewarded campus deans for recruiting and enrolling students.

Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗

Wikidata ↗

CVSA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$133.80
Marktkapitalisierung
$4.55B
P/E (TTM)
19.0
EPS (TTM)
$7.04
Umsatz (TTM)
$1.95B
Dividendenrendite
ROE
17.8%
Verschuldungsgrad
0.5
52W-Spanne
$87 – $156

CVSA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $1.95B
6-point trend, +117.3%
2021-06-30 2026-06-30
EPS $7.04
6-point trend, +417.6%
2021-06-30 2026-06-30
Freier Cashflow $393M
6-point trend, +173.6%
2021-06-30 2026-06-30
Margen 12.9%

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
CVSA
Peer-Median
P/E (TTM)
5-point trend, +216.5%
19.0
15.2
P/S (TTM) (K/V (TTM))
5-point trend, +84.6%
2.3
1.8
P/B (K/B)
5-point trend, +171.7%
3.1
3.6
EV / EBITDA
5-point trend, -55.4%
12.5
Price / FCF (Kurs / FCF)
5-point trend, +113.7%
11.6

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
CVSA
Peer-Median
Operating Margin (Betriebsgewinnmarge)
5-point trend, +238.3%
19.6%
Net Profit Margin (Nettogewinnmarge)
5-point trend, -43.8%
12.9%
11.7%
ROA
5-point trend, -10.0%
8.7%
7.9%
ROE
5-point trend, -16.3%
17.8%
15.8%
ROIC
5-point trend, +520.3%
14.1%

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
CVSA
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
5-point trend, -17.8%
0.5
Current Ratio (Liquiditätsgrad)
5-point trend, -17.9%
1.1
1.7
Quick Ratio
5-point trend, -5.9%
1.0

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
CVSA
Peer-Median
Revenue YoY (Umsatz YoY)
5-point trend, +41.4%
9.3%
Revenue CAGR 3Y (Umsatz CAGR 3J)
5-point trend, +41.4%
10.4%
Revenue CAGR 5Y (Umsatz CAGR 5J)
5-point trend, +41.4%
16.8%
EPS YoY (EPS VjV)
5-point trend, +9.5%
13.9%
Net Income YoY (Nettogewinn YoY)
5-point trend, -19.1%
6.1%

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
CVSA
Peer-Median
EPS (Diluted) (EPS (Verwässert))
5-point trend, +9.5%
$7.04

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
CVSA
Peer-Median

Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR

Dividendenrendite
Ausschüttungsquote
5J Div CAGR
Ex-DatumBetrag
30. November 2016$0,1800
1. Juni 2016$0,1800
2. Dezember 2015$0,1800
3. Juni 2015$0,1800
3. Dezember 2014$0,1800
4. Juni 2014$0,1700
4. Dezember 2013$0,1700
5. Juni 2013$0,1700
28. November 2012$0,1700
19. Juni 2012$0,1500
6. Dezember 2011$0,1500
16. Juni 2011$0,1200
8. Dezember 2010$0,1200
11. Juni 2010$0,1000
9. Dezember 2009$0,1000
12. Juni 2009$0,0800
10. Dezember 2008$0,0800
17. Juni 2008$0,0600
12. Dezember 2007$0,0600
14. Juni 2007$0,0500

CVSA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 10 Analysten
  • Starker Kauf 4 40,0%
  • Kauf 5 50,0%
  • Halten 1 10,0%
  • Verkauf 0 0,0%
  • Starker Verkauf 0 0,0%

12-Monats-Kursziel

4 Analysten · 2026-08-18
Median-Ziel $161.50 +20,7%
Mittelwert-Ziel $159.50 +19,2%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
0.18%
Zeitraum EPS Actual EPS est. Überraschung
30. Juni 2026 $2.09 $1.93 0.16%
31. März 2026 $1.98 $1.76 0.22%
31. Dezember 2025 $2.43 $2.23 0.20%
30. September 2025 $1.75 $1.61 0.14%
30. Juni 2025 $1.66 $1.56 0.10%
31. März 2025 $1.92 $1.69 0.23%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
CVSA $4.24B 17.7 9.3% 12.9% 17.8%
DUOL $8.18B 20.5 38.7% 39.9% 35.6% 72.2%
LAUR $4.81B 17.8 8.6% 16.6% 26.2%
GHC 16.5 2.5% 5.9% 6.5%
LOPE $4.56B 21.6 7.1% 19.5% 28.3%
LRN $3.58B 12.1 4.7% 13.4% 21.3% 37.8%
BFAM $5.64B 30.2 9.2% 6.6% 14.1% 23.8%
MH $2.62B 72.1 0.07% 1.7% 4.6% 80.9%
PRDO $1.83B 12.1 24.2% 18.9% 16.3%
STRA $1.84B 14.8 4.0% 10.0% 7.6%
UTI $1.77B 28.8 14.1% 7.5% 20.3%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 16
Jährliche Gewinn- und Verlustrechnung-Daten für CVSA
Kennzahl Trend 20262025202420232022202120202019
Revenue 5-point trend, +41.4% $1.95B $1.79B $1.58B $1.45B $1.38B · · ·
Cost of Revenue 5-point trend, +26.4% $834M $771M $699M $648M $660M · · ·
SG&A Expense 5-point trend, +29.0% $731M $672M $633M $586M $566M · · ·
Operating Expenses 5-point trend, +20.4% $1.57B $1.45B $1.37B $1.28B $1.31B · · ·
Operating Income 5-point trend, +399.5% $383M $342M $217M $168M $77M · · ·
Interest Expense 5-point trend, -64.9% $45M $52M $64M $63M $129M · · ·
Interest Income · · · · $4M · · ·
Other Non-op 5-point trend, +547.8% $7M $9M $11M $7M $1M · · ·
Pretax Income 5-point trend, +770.2% $345M $299M $164M $112M $-51M · · ·
Income Tax 5-point trend, +600.3% $78M $66M $26M $10M $-16M · · ·
Net Income 5-point trend, -19.1% $252M $237M $137M $93M $311M · · ·
EPS (Basic) 5-point trend, +11.7% $7.18 $6.39 $3.47 $2.08 $6.43 · · ·
EPS (Diluted) 5-point trend, +9.5% $7.04 $6.18 $3.39 $2.05 $6.43 · · ·
Shares (Basic) 5-point trend, -27.6% 35,045,000 37,085,000 39,413,000 44,781,000 48,388,000 · · ·
Shares (Diluted) 5-point trend, -26.2% 35,715,000 38,334,000 40,307,000 45,600,000 48,388,000 · · ·
EBITDA 5-point trend, +376.5% $383M $342M $217M $168M $80M · · ·
Bilanz 28
Jährliche Bilanz-Daten für CVSA
Kennzahl Trend 20262025202420232022202120202019
Cash & Equivalents 8-point trend, +503.9% $406M $200M $219M $272M $347M $275M $416M $67M
Short-term Investments · · · · · · · $9M
Receivables 7-point trend, +141.6% $167M $143M $124M $100M $79M $90M $69M ·
Prepaid Expense 8-point trend, +65.9% $75M $69M $70M $102M $128M $167M $97M $45M
Current Assets 8-point trend, +67.3% $652M $416M $418M $480M $557M $611M $681M $390M
PP&E (Net) 8-point trend, +7.3% $303M $256M $249M $245M $290M $302M $279M $282M
PP&E (Gross) 8-point trend, +13.3% $686M $598M $575M $583M $666M $663M $618M $605M
Accum. Depreciation 8-point trend, +18.5% $383M $342M $326M $339M $376M $362M $339M $323M
Goodwill 8-point trend, +40.0% $961M $961M $961M $961M $961M $960M $310M $687M
Intangibles 8-point trend, +157.7% $754M $765M $777M $812M $874M $924M $138M $293M
Other Non-current Assets 8-point trend, +66.2% $138M $129M $103M $81M $119M $118M $88M $83M
Total Assets 8-point trend, +26.0% $3.01B $2.75B $2.74B $2.81B $3.03B $3.66B $2.27B $2.39B
Accounts Payable 8-point trend, +296.6% $125M $105M $103M $82M $57M $65M $39M $31M
Accrued Liabilities 8-point trend, +5.4% $94M $77M $97M $106M $98M $135M $97M $90M
Current Liabilities 8-point trend, +96.2% $597M $508M $488M $431M $424M $497M $341M $304M
Capital Leases 8-point trend, +15.5% $208M $186M $168M $163M $177M $156M $194M $180M
Deferred Tax 8-point trend, +148.0% $62M $32M $30M $26M $26M $27M $25M $25M
Other Non-current Liabilities 8-point trend, -52.4% $42M $40M $39M $37M $74M $58M $81M $89M
Total Liabilities 8-point trend, +43.4% $1.57B $1.32B $1.37B $1.35B $1.54B $2.37B $959M $1.09B
Long-term Debt 8-point trend, +59.7% $663M $553M $649M $695M $839M $1.61B $287M $415M
Total Debt 5-point trend, -21.0% $663M $553M $649M $695M $839M · · ·
Common Stock 8-point trend, +5.2% $848.0K $839.0K $832.0K $822.0K $818.0K $817.0K $810.0K $806.0K
Retained Earnings 8-point trend, +49.0% $3.03B $2.78B $2.54B $2.40B $2.31B $1.96B $1.97B $2.03B
Treasury Stock 8-point trend, +112.6% $2.29B $2.01B $1.78B $1.51B $1.34B $1.22B $1.16B $1.08B
AOCI 8-point trend, +98.6% $-2M $-2M $-2M $-2M $-2M $-634.0K $-8M $-159M
Stockholders' Equity 8-point trend, +11.7% $1.45B $1.43B $1.37B $1.46B $1.49B $1.28B $1.31B $1.29B
Liabilities + Equity 8-point trend, +26.0% $3.01B $2.75B $2.74B $2.81B $3.03B $3.66B $2.27B $2.39B
Shares Outstanding 8-point trend, -35.7% 34,033,000 35,952,000 37,681,000 82,232,000 81,796,000 81,705,000 81,021,000 52,953,000
Cashflow 16
Jährliche Cashflow-Daten für CVSA
Kennzahl Trend 20262025202420232022202120202019
Stock-based Comp 5-point trend, +82.3% $41M $42M $26M $14M $23M · · ·
Deferred Tax 5-point trend, +600.7% $68M $18M $11M $-5M $-14M · · ·
Amort. of Intangibles 5-point trend, -88.5% $11M $11M $36M $61M $97M · · ·
Restructuring 5-point trend, -75.3% $6M $3M $2M $19M $26M · · ·
Operating Cash Flow 5-point trend, +4337.5% $470M $338M $296M $192M $11M · · ·
CapEx 5-point trend, +150.2% $78M $50M $49M $26M $31M · · ·
Investing Cash Flow 5-point trend, +84.8% $-84M $-42M $-48M $24M $-552M · · ·
Debt Issued 5-point trend, +18.5% $1.01B $10M $2M $0 $850M · · ·
Net Debt Issued 5-point trend, +148.8% $112M $-100M $-50M $-151M $-230M · · ·
Stock Repurchased 5-point trend, +99.9% $240M $213M $262M $123M $120M · · ·
Net Stock Activity 5-point trend, -99.9% $-240M $-213M $-262M $-123M $-120M · · ·
Financing Cash Flow 5-point trend, +57.6% $-180M $-316M $-302M $-289M $-424M · · ·
Net Change in Cash 5-point trend, +121.4% $207M $-20M $-54M $-73M $-966M · · ·
Taxes Paid 5-point trend, -85.5% $14M $33M $31M $12M $94M · · ·
Free Cash Flow 5-point trend, +2003.7% $393M $288M $247M $166M $-21M · · ·
Levered FCF 5-point trend, +436.5% $358M $247M $193M $109M $-106M · · ·
Rentabilität 7
Jährliche Rentabilität-Daten für CVSA
Kennzahl Trend 20262025202420232022202120202019
Operating Margin 5-point trend, +238.3% 19.6% 19.1% 13.7% 11.6% 5.8% · · ·
Net Margin 5-point trend, -43.8% 12.9% 13.3% 8.6% 6.4% 22.9% · · ·
Pretax Margin 5-point trend, +643.4% 17.7% 16.7% 10.3% 7.7% -3.2% · · ·
EBITDA Margin 5-point trend, +238.3% 19.6% 19.1% 13.7% 11.6% 5.8% · · ·
ROA 5-point trend, -10.0% 8.7% 8.6% 4.9% 3.3% 9.7% · · ·
ROE 5-point trend, -16.3% 17.8% 16.5% 10.2% 6.3% 21.3% · · ·
ROIC 5-point trend, +520.3% 14.1% 13.4% 9.0% 7.1% 2.3% · · ·
Liquidität & Solvenz 5
Jährliche Liquidität & Solvenz-Daten für CVSA
Kennzahl Trend 20262025202420232022202120202019
Current Ratio 5-point trend, -17.9% 1.1 0.8 0.9 1.1 1.3 · · ·
Quick Ratio 5-point trend, -5.9% 1.0 0.7 0.7 0.9 1.0 · · ·
Debt / Equity 5-point trend, -17.8% 0.5 0.4 0.5 0.5 0.6 · · ·
LT Debt / Equity 5-point trend, -18.4% 0.5 0.4 0.5 0.5 0.6 · · ·
Interest Coverage 5-point trend, +1256.4% 8.4 6.5 3.4 2.7 0.6 · · ·
Effizienz 2
Jährliche Effizienz-Daten für CVSA
Kennzahl Trend 20262025202420232022202120202019
Asset Turnover 5-point trend, +60.0% 0.7 0.7 0.6 0.5 0.4 · · ·
Receivables Turnover 5-point trend, -21.6% 12.6 13.4 14.1 16.2 16.1 · · ·
Pro Aktie 5
Jährliche Pro Aktie-Daten für CVSA
Kennzahl Trend 20262025202420232022202120202019
Book Value / Share 5-point trend, +27.6% $42.49 $39.88 $36.33 $34.44 $33.31 · · ·
Revenue / Share 5-point trend, +90.9% $54.71 $46.65 $39.31 $31.82 $28.67 · · ·
Cash Flow / Share 5-point trend, +6014.9% $13.17 $8.81 $7.34 $4.45 $0.22 · · ·
Cash / Share 5-point trend, +55.4% $11.94 $5.55 $5.82 $6.47 $7.68 · · ·
EPS (TTM) 5-point trend, +9.5% $7.04 $6.18 $3.39 $2.05 $6.43 · · ·
Wachstumsraten 9
Jährliche Wachstumsraten-Daten für CVSA
Kennzahl Trend 20262025202420232022202120202019
Revenue YoY 5-point trend, -82.7% 9.3% 12.8% 9.2% 5.0% 53.7% · · ·
Revenue CAGR 3Y 4-point trend, -44.3% 10.4% 9.0% 20.8% 18.8% · · · ·
Revenue CAGR 5Y 2-point trend, +7.6% 16.8% 15.6% · · · · · ·
EPS YoY 5-point trend, -96.3% 13.9% 82.3% 65.4% -68.1% 372.8% · · ·
EPS CAGR 3Y 3-point trend, +42.9% 50.9% -1.3% 35.6% · · · · ·
EPS CAGR 5Y 38.9% · · · · · · ·
Net Income YoY 5-point trend, -98.2% 6.1% 73.3% 46.5% -70.0% 344.1% · · ·
Net Income CAGR 3Y 3-point trend, +56.6% 39.2% -8.6% 25.0% · · · · ·
Net Income CAGR 5Y 29.1% · · · · · · ·
Bewertung (TTM) 13
Jährliche Bewertung (TTM)-Daten für CVSA
Kennzahl Trend 20262025202420232022202120202019
Revenue TTM 5-point trend, +41.4% $1.95B $1.79B $1.58B $1.45B $1.38B · · ·
Net Income TTM 5-point trend, -19.1% $252M $237M $137M $93M $311M · · ·
Market Cap 5-point trend, +161.1% $4.24B $4.57B $2.57B $1.45B $1.63B · · ·
Enterprise Value 5-point trend, +112.5% $4.50B $4.93B $3.00B $1.87B $2.12B · · ·
P/E 5-point trend, +216.5% 17.7 20.6 20.1 16.8 5.6 · · ·
P/S 5-point trend, +84.6% 2.2 2.6 1.6 1.0 1.2 · · ·
P/B 5-point trend, +171.7% 2.9 3.2 1.9 1.0 1.1 · · ·
P / Cash Flow 5-point trend, -94.2% 9.0 13.5 8.7 7.2 155.9 · · ·
P / FCF 5-point trend, +113.7% 10.8 15.9 10.4 8.8 -78.8 · · ·
EV / EBITDA 5-point trend, -55.4% 11.7 14.4 13.8 11.1 26.3 · · ·
EV / FCF 5-point trend, +111.2% 11.5 17.1 12.2 11.3 -102.6 · · ·
EV / Revenue 5-point trend, +50.3% 2.3 2.8 1.9 1.3 1.5 · · ·
Earnings Yield 5-point trend, -68.4% 5.7% 4.9% 5.0% 6.0% 17.9% · · ·

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung
2026-06-302025-06-302024-06-302023-06-302022-12-31
Umsatz $1.95B$1.79B$1.58B$1.45B
Betriebsgewinnmarge % 19.6%19.1%13.7%11.6%
Nettoergebnis $252M$237M$137M$93M
Verwässerte EPS $7.04$6.18$3.39$2.05
Bilanz
2026-06-302025-06-302024-06-302023-06-302022-12-31
Fremdkapital / Eigenkapital 0.50.40.50.5
Liquiditätsgrad 1.10.80.91.1
Quick Ratio 1.00.70.70.9
Cashflow
2026-06-302025-06-302024-06-302023-06-302022-12-31
Freier Cashflow $393M$288M$247M$166M

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Institutionelle Eigentümer (13F) 402 Einreicher · $3.0B gesamt · Stand 30. Juni 2026

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
61 (+15 vs. Vorquartal) 30 (-23 vs. Vorquartal) 137 (+3 vs. Vorquartal) 121 (-7 vs. Vorquartal) +4.5M

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
VANGUARD GROUP INC $418.746.711 4.047.035 14,07% Aktien
VANGUARD PORTFOLIO MANAGEMENT LLC $297.558.184 2.386.958 10,00% Aktien
FMR LLC $280.021.015 2.246.278 9,41% Aktien
DIMENSIONAL FUND ADVISORS LP $208.992.241 1.676.499 7,02% Aktien
VANGUARD CAPITAL MANAGEMENT LLC $183.742.358 1.473.948 6,17% Aktien
STATE STREET CORP $173.212.203 1.389.477 5,82% Aktien
Capital World Investors $132.593.736 1.063.643 4,46% Aktien
GEODE CAPITAL MANAGEMENT, LLC $95.719.361 767.678 3,22% Aktien
WELLINGTON MANAGEMENT GROUP LLP $87.910.731 705.204 2,95% Aktien
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $78.581.301 630.365 2,64% Aktien
Alyeska Investment Group, L.P. $68.807.458 551.961 2,31% Aktien
Fisher Asset Management, LLC $63.050.035 505.776 2,12% Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $60.245.186 483.276 2,02% Aktien
NEUMEIER POMA INVESTMENT COUNSEL LLC $44.010.839 353.047 1,48% Aktien
FRONTIER CAPITAL MANAGEMENT CO LLC $37.728.848 302.654 1,27% Aktien
TWO SIGMA INVESTMENTS, LP $32.342.164 259.443 1,09% Aktien
VANGUARD FIDUCIARY TRUST CO $30.437.360 244.163 1,02% Aktien
PRINCIPAL FINANCIAL GROUP INC $26.065.659 209.094 0,88% Aktien
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $23.386.341 187.601 0,79% Aktien
SG Capital Management LLC $22.238.845 178.396 0,75% Aktien
TWO SIGMA ADVISERS, LP $19.876.587 192.100 0,67% Aktien
ALGERT GLOBAL LLC $19.323.048 155.006 0,65% Aktien
MORGAN STANLEY $18.731.418 150.260 0,63% Aktien
Public Sector Pension Investment Board $17.393.810 139.530 0,58% Aktien
Corient Private Wealth LP $16.950.396 135.973 0,57% Aktien
WESTPORT ASSET MANAGEMENT INC $15.677.117 125.759 0,53% Aktien
Bank of New York Mellon Corp $15.262.248 122.431 0,51% Aktien
PRUDENTIAL FINANCIAL INC $14.091.816 113.042 0,47% Aktien
MACKENZIE FINANCIAL CORP $13.510.152 108.376 0,45% Aktien
Qube Research & Technologies Ltd $12.647.380 101.455 0,43% Aktien
BANK OF AMERICA CORP /DE/ $12.502.650 100.294 0,42% Aktien
RHUMBLINE ADVISERS $10.647.181 85.410 0,36% Aktien
MILLENNIUM MANAGEMENT LLC $9.671.247 77.581 0,33% Aktien
Foresight Group Ltd Liability Partnership $9.636.366 77.264 0,32% Aktien
AMERICAN CENTURY COMPANIES INC $9.436.388 75.697 0,32% Aktien
ALLIANCEBERNSTEIN L.P. $8.879.782 77.048 0,30% Aktien
BlackRock, Inc. $8.832.036 70.849 0,30% Aktien
LAZARD ASSET MANAGEMENT LLC $8.696.157 69.759 0,29% Aktien
Swiss National Bank $8.638.938 69.300 0,29% Aktien
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $8.557.000 68.639 0,29% Aktien
Universal- Beteiligungs- und Servicegesellschaft mbH $8.419.536 67.540 0,28% Aktien
Hillsdale Investment Management Inc. $8.077.968 64.800 0,27% Aktien
BNP PARIBAS FINANCIAL MARKETS $8.030.847 64.422 0,27% Aktien
RENAISSANCE GROUP LLC $7.608.748 61.036 0,26% Aktien
AMERIPRISE FINANCIAL INC $7.563.622 60.674 0,25% Aktien
GOLDMAN SACHS GROUP INC $7.528.716 60.394 0,25% Aktien
Allianz Asset Management GmbH $7.053.013 56.578 0,24% Aktien
LONESTAR CAPITAL MANAGEMENT LLC $6.856.300 55.000 0,23% Aktien
Legal & General Group Plc $6.503.387 52.169 0,22% Aktien
Phocas Financial Corp. $6.345.443 50.902 0,21% Aktien
WEDGE CAPITAL MANAGEMENT L L P/NC $6.335.869 54.975 0,21% Aktien
FIRST TRUST ADVISORS LP $6.152.968 49.358 0,21% Aktien
ExodusPoint Capital Management, LP $5.906.141 47.378 0,20% Aktien
KESTREL INVESTMENT MANAGEMENT CORP $5.896.418 47.300 0,20% Aktien
LEUTHOLD GROUP, LLC $5.622.914 45.106 0,19% Aktien
ENVESTNET ASSET MANAGEMENT INC $5.482.297 43.978 0,18% Aktien
Connor, Clark & Lunn Investment Management Ltd. $5.313.757 42.626 0,18% Aktien
LGT Fund Management Co Ltd. $4.992.633 40.050 0,17% Aktien
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $4.840.500 42.000 0,16% Aktien
Trexquant Investment LP $4.814.120 38.618 0,16% Aktien
FARLEY CAPITAL L.P. $4.644.333 37.256 0,16% Aktien
SEI INVESTMENTS CO $4.541.490 36.431 0,15% Aktien
CHURCHILL MANAGEMENT Corp $4.474.806 35.171 0,15% Aktien
INTECH INVESTMENT MANAGEMENT LLC $4.270.726 34.259 0,14% Aktien
VANGUARD ASSET MANAGEMENT, Ltd $3.909.088 31.358 0,13% Aktien
HSBC HOLDINGS PLC $3.726.330 29.614 0,13% Aktien
PANAGORA ASSET MANAGEMENT INC $3.568.268 28.624 0,12% Aktien
Smith Group Asset Management, LLC $3.304.113 26.505 0,11% Aktien
OP Asset Management Ltd $3.295.387 26.435 0,11% Aktien
Horizon Investments, LLC $3.257.730 21.000 0,11% Aktien
Atom Investors LP $3.165.242 25.391 0,11% Aktien
FORMULA GROWTH LTD $3.140.933 25.196 0,11% Aktien
STATE OF WISCONSIN INVESTMENT BOARD $3.064.891 24.586 0,10% Aktien
BARCLAYS PLC $2.926.019 23.472 0,10% Aktien
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $2.840.627 22.787 0,10% Aktien
NewEdge Wealth, LLC $2.790.514 22.385 0,09% Aktien
Elo Mutual Pension Insurance Co $2.724.943 21.859 0,09% Aktien
RENAISSANCE TECHNOLOGIES LLC $2.717.588 21.800 0,09% Aktien
NEW YORK STATE COMMON RETIREMENT FUND $2.695.523 21.623 0,09% Aktien
MetLife Investment Management, LLC $2.499.807 20.053 0,08% Aktien
Global Alpha Capital Management Ltd. $2.430.995 19.501 0,08% Aktien
FIFTH THIRD BANCORP $2.403.502 19.280 0,08% Aktien
ROYCE & ASSOCIATES LP $2.376.768 19.066 0,08% Aktien
Boston Partners $2.293.116 18.393 0,08% Aktien
Quantinno Capital Management LP $2.288.134 18.355 0,08% Aktien
Grantham, Mayo, Van Otterloo & Co. LLC $2.256.097 18.098 0,08% Aktien
LGT CAPITAL PARTNERS LTD. $2.206.482 17.700 0,07% Aktien
IEQ CAPITAL, LLC $2.199.751 17.646 0,07% Aktien
VIRGINIA RETIREMENT SYSTEMS ET Al $2.141.829 20.700 0,07% Aktien
Bridgewater Associates, LP $2.138.044 17.151 0,07% Aktien
CITIGROUP INC $2.106.879 16.901 0,07% Aktien
CITADEL ADVISORS LLC $2.106.754 16.900 0,07% Kaufoption
Banque Cantonale Vaudoise $2.082.000 16.700 0,07% Aktien
Mariner, LLC $2.075.942 16.653 0,07% Aktien
MANUFACTURERS LIFE INSURANCE COMPANY, THE $2.064.120 16.558 0,07% Aktien
Illinois Municipal Retirement Fund $2.054.147 16.478 0,07% Aktien
Gotham Asset Management, LLC $2.014.256 16.158 0,07% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1.982.094 15.900 0,07% Kaufoption
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $1.977.731 15.865 0,07% Aktien
Zurcher Kantonalbank (Zurich Cantonalbank) $1.902.312 15.260 0,06% Aktien

Unternehmensinsider 111 Insider · 46 Führungskräfte · 24 Direktoren

Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Daniel Hamburger President and CEO 31. August 2015 S 142.136 0 0 $0
Michael O Randolfi SVP, Chief Financial Officer 28. August 2020 F 84.391 0 0 $0
Timothy J Wiggins SVP & Chief Financial Officer 25. Februar 2016 S 44.939 0 0 $0
Richard Gunst Chief Financial Officer 1. Februar 2012 M 9.356 0 0 $0
Amelia Manning President, Chamberlain Univ. 15. Juli 2026 A 4.317 0 0 $0
Karen Sue Cox President, Chamberlain Univ. 8. Mai 2026 S 31.596 0 1 $-249.000
Scott Liles President, Medical and Vet 15. April 2026 F 13.103 0 0 $0
Evan Trent President, Adtalem Elevate 13. November 2025 F 24.134 0 0 $0
Thiago Aguiar Sayao Group President, Business &Law 28. Februar 2020 S 1.830 0 0 $0
Carlos Filgueiras Group President, Tech/Business 13. Februar 2019 S 11.775 0 0 $0
Donna M Loraine President, Carrington Colleges 6. November 2018 M 6.701 0 0 $0
Susan Groenwald President, Chamberlain 9. Februar 2018 M 34.402 0 0 $0
John P Roselli President, Becker Professional 1. September 2017 S 13.730 0 0 $0
Eric P. Dirst President, ATGE Shared Ops 31. August 2017 S 14.800 0 0 $0
Robert A Paul President, DeVry University 25. August 2017 M 28.426 0 0 $0
Steven Riehs President, Med, Prof & Online 2. September 2016 M 28.062 0 0 $0
Jeffrey Richard Akens President, Carrington College 29. August 2015 F 6.752 0 0 $0
Christopher Caywood President, Online Services 1. März 2013 F 7.378 0 0 $0
Andrew A Jeon President, DeVry Medical Int'l 2. November 2012 F 5.655 0 0 $0
William B. Hughson President, Medical & 29. August 2012 A 2.143 0 0 $0
Manjunath Gangadharan VP, Chief Accounting Officer 18. Mai 2026 F 5.271 0 1 $-128.072
Michael Betz Pres. Walden University & CDO 13. November 2025 F 33.286 0 0 $0
Maurice Herrera SVP - Chief Marketing Officer 13. November 2025 F 20.584 0 0 $0
Megan Noel Chief Corp. Affairs Officer 12. November 2025 A 2.226 0 0 $0
Sara Hill CHRO 12. November 2025 A 10.276 0 0 $0
Blake Simpson SVP, Chief Comms & CA Officer 5. Dezember 2024 F 8.795 0 0 $0
Steven Tom SVP Chief Customer Officer 13. November 2024 A 13.255 0 0 $0
Cheryl James SVP, CHRO 28. Februar 2024 F 17.485 0 0 $0
John W Danaher MD Pres. - Adtalem Med & Vet 25. August 2023 F 38.718 0 0 $0
James Raymond Bartholomew SVP - Chamberlain University 26. August 2022 F 6.418 0 0 $0
Holland Katherine Alice Boden Group Pres, Adtalem Health 30. August 2021 F 32.148 0 0 $0
Fernando Lau SVP, Chief Marketing Officer 28. August 2021 F 19.253 0 0 $0
Christopher C Nash SVP, Chief Information Officer 28. August 2021 F 25.741 0 0 $0
Donna Jennings SVP, Human Resources 28. August 2021 F 30.898 0 0 $0
Chaka M Patterson SVP and General Counsel 28. August 2020 F 5.202 0 0 $0
Mehul R Patel Group Pres, Financial Services 7. November 2019 F 11.258 0 0 $0
Kathleen Carroll Vice President, Controller 28. August 2019 A 5.497 0 0 $0
Lisa M Sodeika SVP, Corporate Affairs 28. August 2019 A 24.151 0 0 $0
Patrick J Unzicker Principal Financial Officer 27. August 2019 F 36.360 0 0 $0
Catherine C. Anderson SVP, Strategy & Innovation 26. August 2019 F 6.025 0 0 $0
Gena L Ashe SVP, CLO and Secretary 23. August 2017 A 4.420 0 0 $0
Gregory S Davis SVP and General Counsel 1. September 2016 S 22.433 0 0 $0
Adriano Allegrini VP, Strategy and Bus. Develop. 29. August 2015 F 7.004 0 0 $0
Sharon Thomas Parrott SVP, Gov. & Regulatory Affairs 5. November 2014 A 5.610 0 0 $0
David J Pauldine Executive Vice President & 25. April 2014 M 30.242 0 0 $0
Thomas C Shepherd Executive Vice President and 27. Mai 2011 M 0 0 0 $0
Michael W Malafronte Direktor 11. März 2026 P 25.395 5 0 $3.844.716
William V Krehbiel Direktor 13. November 2025 F 16.303 0 0 $0
Betty M. Vandenbosch Direktor 13. November 2025 F 2.584 0 0 $0
Kenneth J Phelan Direktor 13. November 2025 F 19.836 1 0 $49.931

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 1 Beteiligung

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
International Value Advisers, LLC, Charles de Vaulx ×18 Einreichungen 7. August 2020 Erste Einreichung SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 79 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
PSCD · Invesco Exchange-Traded Fund Trust … 1,82% 3.165 SH 8. August 2026 Täglich
PSL · Invesco Exchange-Traded Fund Trust 1,76% 10.579 SH 8. August 2026 Täglich
MYLD · Cambria ETF Trust 0,94% 2.418 NS 30. April 2026 N-PORT
XSHQ · Invesco Exchange-Traded Fund Trust … 0,91% 20.685 SH 8. August 2026 Täglich
RZG · Invesco Exchange-Traded Fund Trust 0,88% 8.705 SH 8. August 2026 Täglich
CGMM · Capital Group Equity ETF Trust I 0,80% 190.016 NS 31. Mai 2026 N-PORT
VUSE · ETF Series Solutions 0,53% 31.159 NS 31. Mai 2026 N-PORT
IJT · iShares Trust 0,47% 316.256 SH 8. August 2026 Täglich
CAFG · Pacer Funds Trust 0,47% 919 NS 30. April 2026 N-PORT
VIOG · VANGUARD ADMIRAL FUNDS 0,46% 40.509 SH 8. August 2026 Täglich
CALF · Pacer Funds Trust 0,46% 136.827 NS 30. April 2026 N-PORT
FYC · First Trust Exchange-Traded AlphaDE… 0,33% 29.825 NS 30. April 2026 N-PORT
QVMS · Invesco Exchange-Traded Fund Trust … 0,27% 4.982 SH 8. August 2026 Täglich
XJR · iShares Trust 0,26% 4.021 SH 8. August 2026 Täglich
IWO · iShares Trust 0,26% 312.826 SH 8. August 2026 Täglich
PRFZ · Invesco Exchange-Traded Fund Trust 0,26% 52.359 SH 8. August 2026 Täglich
VTWG · VANGUARD SCOTTSDALE FUNDS 0,25% 36.861 SH 8. August 2026 Täglich
IJR · iShares Trust 0,23% 2.075.461 SH 8. August 2026 Täglich
VIOO · VANGUARD ADMIRAL FUNDS 0,23% 119.030 SH 8. August 2026 Täglich
JPSE · J.P. Morgan Exchange-Traded Fund Tr… 0,21% 10.711 NS 30. April 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0,21% 4.228 SH 8. August 2026 Täglich
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,21% 13.071 NS 30. April 2026 N-PORT
SMDX · Tidal Trust III 0,20% 2.228 NS 30. April 2026 N-PORT
AVSC · AMERICAN CENTURY ETF TRUST 0,20% 46.807 NS 31. Mai 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0,18% 1.290 NS 30. April 2026 N-PORT
DFAT · Dimensional ETF Trust 0,18% 217.961 NS 30. April 2026 N-PORT
SAA · ProShares Trust 0,18% 412 NS 31. Mai 2026 N-PORT
FSMD · FIDELITY COVINGTON TRUST 0,14% 29.761 NS 30. April 2026 N-PORT
GMOV · GMO ETF Trust 0,14% 1.078 NS 31. Mai 2026 N-PORT
IWM · iShares Trust 0,13% 875.500 SH 8. August 2026 Täglich
ISCG · iShares Trust 0,13% 10.563 SH 8. August 2026 Täglich
VTWO · VANGUARD SCOTTSDALE FUNDS 0,13% 198.216 SH 8. August 2026 Täglich
FNDA · SCHWAB STRATEGIC TRUST 0,13% 98.138 NS 31. Mai 2026 N-PORT
RWJ · Invesco Exchange-Traded Fund Trust … 0,13% 19.006 SH 8. August 2026 Täglich
SMLF · iShares Trust 0,12% 41.596 SH 8. August 2026 Täglich
VFQY · VANGUARD WELLINGTON FUND 0,12% 4.599 SH 8. August 2026 Täglich
PKW · Invesco Exchange-Traded Fund Trust 0,12% 15.066 SH 8. August 2026 Täglich
VCR · VANGUARD WORLD FUND 0,12% 67.714 SH 8. August 2026 Täglich
RSSL · Global X Funds 0,12% 14.797 NS 30. April 2026 N-PORT
FYX · First Trust Exchange-Traded AlphaDE… 0,11% 12.017 NS 30. April 2026 N-PORT
GSSC · Goldman Sachs ETF Trust 0,11% 9.365 NS 31. Mai 2026 N-PORT
FDIS · FIDELITY COVINGTON TRUST 0,10% 15.550 NS 30. April 2026 N-PORT
ITWO · ProShares Trust 0,10% 1.606 NS 31. Mai 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,10% 5.421 SH 8. August 2026 Täglich
DFAS · Dimensional ETF Trust 0,09% 111.249 NS 30. April 2026 N-PORT
VBR · VANGUARD INDEX FUNDS 0,09% 470.701 SH 8. August 2026 Täglich
SCHA · SCHWAB STRATEGIC TRUST 0,09% 165.865 NS 31. Mai 2026 N-PORT
ESML · iShares Trust 0,07% 16.803 SH 8. August 2026 Täglich
FAD · First Trust Exchange-Traded AlphaDE… 0,07% 2.779 NS 30. April 2026 N-PORT
ISCB · iShares Trust 0,06% 1.479 SH 8. August 2026 Täglich